Viewing Study NCT04959305


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-12 @ 12:34 PM
Study NCT ID: NCT04959305
Status: COMPLETED
Last Update Posted: 2022-07-14
First Post: 2021-07-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Sponsor: Hanmi Pharmaceutical Company Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module